Literature DB >> 12718878

A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells.

Yibin Kang1, Chang-Rung Chen, Joan Massagué.   

Abstract

Genome-wide transcriptional profiling of human epithelial cells revealed that repression of Id inhibitors of differentiation (Id1, Id2, and Id3) is a general feature of the TGFbeta cytostatic program. Opposite responses of Id1 to TGFbeta and the related factor BMP are dictated by the specific ability of the TGFbeta mediator, Smad3, to activate expression of stress response factor ATF3 and then recruit this factor to the Id1 promoter. Thus, a Smad3-mediated primary gene response, ATF3 induction, enables Smad3 to participate in an ATF3-mediated, secondary gene response. As a common target of TGFbeta/Smad signals and stress signals via p38 kinase, ATF3 additionally serves to channel synergy between these pathways in the response of epithelial cells to stress and injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718878     DOI: 10.1016/s1097-2765(03)00109-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  209 in total

1.  The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor.

Authors:  Hongbo Wang; Ming Jiang; Hongmei Cui; Mengqian Chen; Ralph Buttyan; Simon W Hayward; Tsonwin Hai; Zhengxin Wang; Chunhong Yan
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

2.  Smurf2-mediated ubiquitination and degradation of Id1 regulates p16 expression during senescence.

Authors:  Yahui Kong; Hang Cui; Hong Zhang
Journal:  Aging Cell       Date:  2011-10-07       Impact factor: 9.304

Review 3.  Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Rik Derynck
Journal:  Cells Tissues Organs       Date:  2010-11-02       Impact factor: 2.481

4.  Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells.

Authors:  Zhuo Chen; De-quan Li; Louis Tong; Paul Stewart; Claire Chu; Stephen C Pflugfelder
Journal:  Mol Vis       Date:  2006-08-23       Impact factor: 2.367

5.  Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Smurf2 up-regulation activates telomere-dependent senescence.

Authors:  Hong Zhang; Stanley N Cohen
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

7.  Inhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in mice.

Authors:  Huimin Zhang; William E Lawson; Vasiliy V Polosukhin; Ambra Pozzi; Timothy S Blackwell; Ying Litingtung; Chin Chiang
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

8.  Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.

Authors:  Binwu Tang; Naomi Yoo; Mary Vu; Mizuko Mamura; Jeong-Seok Nam; Akira Ooshima; Zhijun Du; Pierre-Yves Desprez; Miriam R Anver; Aleksandra M Michalowska; Joanna Shih; W Tony Parks; Lalage M Wakefield
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

9.  Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.

Authors:  Daizo Koinuma; Shuichi Tsutsumi; Naoko Kamimura; Hirokazu Taniguchi; Keiji Miyazawa; Makoto Sunamura; Takeshi Imamura; Kohei Miyazono; Hiroyuki Aburatani
Journal:  Mol Cell Biol       Date:  2008-10-27       Impact factor: 4.272

Review 10.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.